Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04837183 · ClinicalTrials.gov registry record
Catheter Ablation of Ventricular Arrhythmia Reduces Skin Sympathetic Activity
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 30
- Enrollment target
NCT04837183: Clinical Trial study, sponsored by Mayo Clinic.
NCT04837183 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04837183 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study is being done to determine whether there is an increase in sympathetic nerve activity before the onset of ventricular arrhythmias or irregular heartbeat rhythm. In addition, this study is looking at the relationship between sympathetic nerve activity and how patients with ventricular arrhythmias respond to catheter ablation treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2024-01-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04837183
The ClinicalTrials.gov registry entry for NCT04837183 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04837183 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04837183 about?
NCT04837183 is a clinical study titled "Catheter Ablation of Ventricular Arrhythmia Reduces Skin Sympathetic Activity". This study is being done to determine whether there is an increase in sympathetic nerve activity before the onset of ventricular arrhythmias or irregular heartbeat rhythm. In addition, this study is looking at the relationship between sympathetic nerve activity and how patients with ventricular arrh...
What is the current status of trial NCT04837183?
This trial is currently terminated. The enrollment target is 30 participants. The study started on 2021-11-15. Estimated completion is 2024-01-01.
Who is sponsoring clinical trial NCT04837183?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.